Category | Nb | QFN, N (%) | ||
---|---|---|---|---|
Positive, N (%) | Negative, N (%) | Intermediate, N (%) | ||
HIV positive | 21 | 9 (42.9) | 11 (52.4) | 1 (4.8) |
HIV negative | 115 | 66 (57.4) | 48 (41.7) | 1 (0.9) |
CD4ā<ā200Ā cells/µl | 25 | 11 (44.0) | 13 (52.0) | 1 (4) |
CD4āā„ā200Ā cells/µl | 112 | 65 (58.0) | 46 (41.1) | 1 (0.9) |
Smear positive | 12 | 5 (41.7) | 7 (58.3) | āa |
Smear negative | 124 | 70 (56.5) | 52 (41.9) | 2 (1.6) |
Culture positive | 37 | 26 (70.3) | 10 (27.0) | 1 (2.7) |
Culture negative | 99 | 49 (49.5) | 49 (49.5) | 1 (1.0) |
BCG vaccinated | 40 | 23 (57.5) | 17 (42.5) | āa |
BCG not vaccinated | 96 | 52 (54.2) | 42 (43.8) | 2 (2.0) |
Sputum with blood | 28 | 19 (67.9) | 9 (32.1) | āa |
Breath shortness | 90 | 52 (57.8) | 38 (42.2) | āa |
Night sweats | 99 | 53 (53.5) | 44 (44.4) | 2 (2.1) |
Chest pain | 110 | 64 (58.2) | 45 (40.9) | 1 (0.9) |
Weight loss | 91 | 49 (53.8) | 40 (44.0) | 2 (2.2) |